Go Unlimited with Magzter GOLD

Go Unlimited with Magzter GOLD

Get unlimited access to 10,000+ magazines, newspapers and Premium stories for just

$149.99
 
$74.99/Year

Try GOLD - Free

'Deadly Risk' of Fat-Loss Drugs

Newsweek Europe

|

March 22, 2024

Diabetes treatment Ozempic has become popular among dieters due to its weightloss side effect, but a study warns of a link between the drug and suicidal thoughts

- PANDORA DEWAN

'Deadly Risk' of Fat-Loss Drugs

"MIRACLE" FAT-MELTING DRUG OZEMPIC HAS been linked in a study to a series of rare but potentially fatal psychiatric episodes, scientists have warned.

The injectable prescription drug was developed to manage blood sugar levels in patients with Type 2 diabetes, but it has gained popularity and gone viral on social media due to one sought-after side effect: weight loss.

Ozempic is based on a naturally occurring human hormone called glucagon-like peptide 1, which plays an important role in regulating appetite and blood sugar levels. Its active ingredient is a molecule called semaglutide, which mimics the structure of this GLP-1 hormone and activates its receptors.

In doing so, semaglutide induces feelings of fullness while delaying the emptying of our stomach, making us less hungry and therefore less likely to overeat.

Semaglutide is also used in Ozempic's sister drug, Wegovy, which has been approved by the FDA for chronic weight management. Between the start of 2020 and the end of 2022, prescriptions of GLP-1 mimic medications like semaglutide increased by 300 percent across the U.S., according to health care analytics firm Trilliant Health.

The drug has since been endorsed by celebrities and influencers, with #ozempic reaching over 1.4 billion views on TikTok. However, when used as a weight-loss drug, semaglutide has been shown to have some uncomfortable side effects.

Most studies into these have focused on gut problems, but a new study, published in the International Journal of Clinical Pharmacy, has highlighted a concerning association between semaglutide and adverse psychiatric events, including depression, anxiety and suicidal thoughts. Pharmaceutical manufacturer Novo Nordisk, which produces Ozempic and Wegovy, cited the FDA saying that no evidence was found regarding suicidal thoughts or actions caused by these medicines.

MORE STORIES FROM Newsweek Europe

Newsweek Europe

Newsweek Europe

Chasing Gratitude

Ultra-runner Hunter Leininger on how he keeps smiling through blisters and sickness on his extreme adventures

time to read

6 mins

October 03, 2025

Newsweek Europe

Newsweek Europe

The Motor City Comeback

Outgoing Mayor Mike Duggan tells Newsweek how Detroit rebuilt pride and prosperity after bankruptcy—and why the city's resurgence is powered by its people

time to read

6 mins

October 03, 2025

Newsweek Europe

Newsweek Europe

Robin Wright

ROBIN WRIGHT KNEW THAT IN HER NEW PRIME VIDEO SHOW THE GIRL-friend—which she developed and is starring in—she would have to fight the potential for melodrama, because “it could easily go there.”

time to read

2 mins

October 03, 2025

Newsweek Europe

Newsweek Europe

Killer Instinct

THE KEY TO THURSDAY MURDER CLUB STAR HELEN MIRREN'S LONG AND STILL-FLOURISHING CAREER IS STANDING BY HER CHOICESWHICH HAVE LED HER TO OSCAR-, EMMY AND TONY-WINNING SUCCESS

time to read

8 mins

October 03, 2025

Newsweek Europe

Newsweek Europe

Mae Martin

FOR THEIR NEW SHOW WAYWARD, MAE MAR-tin “wanted a friendship at [its] heart.”

time to read

1 mins

October 03, 2025

Newsweek Europe

Newsweek Europe

AMERICA'S MOST Admired WORKPLACES 2026

WHEN PEOPLE CONSIDER THEIR DREAM JOB, they often put companies they admire at the top of the list.

time to read

4 mins

October 03, 2025

Newsweek Europe

Newsweek Europe

Tiny Lives, Mighty Care

An exclusive look inside The Hospital for Sick Children, the world's top pediatric hospital

time to read

5 mins

October 03, 2025

Newsweek Europe

Newsweek Europe

WORLD'S BEST SPECIALIZED HOSPITALS 2026

SPECIALIZED HOSPITALS ARE SEEING EXPLOSIVE growth as patients search for physicians that provide advanced, targeted care.

time to read

1 min

September 26, 2025

Newsweek Europe

Newsweek Europe

Monster Smash

KPop Demon Hunters' directors reveal what's next for Netflix's chart-topping film

time to read

5 mins

September 26, 2025

Newsweek Europe

Newsweek Europe

Heart and Soul Food

Chef Marcus Samuelsson on removing barriers to the industry and reshaping America's tastes

time to read

5 mins

September 26, 2025

Listen

Translate

Share

-
+

Change font size